Skip to main content
Caplight Logo









Touchlight

Touchlight

Private
HamptonHealthcare & Life Scienceshttps://touchlight.com

Last Round

Grant

May 9, 2024

Est. Valuation

$1B

Total Funding Raised

$133.4M

Company Overview

Touchlight operates in Healthcare & Life Sciences and is based in Hampton. Its latest recorded funding round was a Grant round in May 2024.

Touchlight is a biotechnology company that provides enzymatic DNA manufacturing services and proprietary doggybone DNA (dbDNA) technology to support the development of genetic medicines, including mRNA, viral vectors, and vaccines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Touchlight Comparables

Compare Touchlight with similar companies based on industry and business-model similarity.

Touchlight comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elegen
79%
Telesis Bio
76%
GenScript
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Touchlight Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 9, 2024
GrantMar 29, 2023
GrantDec 1, 2022
VC RoundSep 15, 2021
Series BMar 11, 2021
Grant
Mar 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jonny Ohlson

Chair Group CEO, CEO, Executive Chair

Executive Team

Karen Fallen

Chief Executive Officer

Executive Team

Lauren Birchard

PA To CEO Office Manager

Executive Team

Alistair Howes

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Touchlight Investors

Notable investors and investment history

Touchlight investors
InvestorRounds
UK Department for Science, Innovation and TechnologyGrant
Novator PartnersVC Round
DowningVC Round
Bridford GroupVC Round, Series B
Gates FoundationGrant
Innovate UKGrant
The Bill & Melinda Gates Foundation TrustGrant
Book a demo to see all 9 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Developing a hepatitis B/D vaccine in partnership with SVF Vaccines.

  • Apr 9, 2026

    Partnering with SVF Vaccines to advance hepatitis B/D vaccine.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_awardNov 3, 2026

    Touchlight earns the Innovation Catalyst award for its cell-free Doggybone DNA (dbDNA) platform.

  • recognized_asOct 7, 2026

    Touchlight is shortlisted for Innovation Catalyst, Manufacturing Excellence, and Sustainable Pharma Excellence at the CPHI Pharma Awards 2026 and receives the winner’s award at the ceremony in Italy on Oct 6th '26.

  • attends_eventOct 7, 2026

    Touchlight attends CPHI Milan, where the winner’s award is presented to it at a ceremony in Italy on Oct 6th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Touchlight Filings

Explore SEC and related filing metadata, where available.

Touchlight filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Touchlight's valuation, stock price, and market status.

Is Touchlight a public or private company?

Touchlight is a private company.

What is the current stock price of Touchlight?

Touchlight is a private company, so its shares have no public market price. Caplight tracks Touchlight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Touchlight worth (valuation)?

Touchlight's valuation is estimated at $1.0B based on funding round data.

Can I buy Touchlight stock?

Touchlight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Touchlight's last funding round?

Touchlight's most recent funding round was Grant on May 9, 2024.

Who are the main investors in Touchlight?

Key investors in Touchlight include Novator Partners, Bridford Group, Innovate UK, Novator Capital Advisers.

Will Touchlight IPO soon?

No public IPO plans have been announced for Touchlight.

How can I track Touchlight secondary market activity?

Caplight tracks bids, offers, and trades in Touchlight's shares on secondary markets.

Firmographic Details

HeadquartersHampton
Employee Range133
Year Founded2007
Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?